CIK 0001689375 · Accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813983399
- Phone
- 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-05 | Dowden Nathan J President & COO | Shares withheld for taxes | −171 | $15.13 | $3K | 128,299 |
| 2024-09-05 | Sethuraman Natarajan Chief Scientific Officer | Shares withheld for taxes | −167 | $15.13 | $3K | 187,058 |
| 2024-09-05 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −165 | $15.13 | $2K | 79,681 |
| 2024-09-04 | Doshi Dipal CEO | Shares withheld for taxes | −4,744 | $15.42 | $73K | 326,579 |
| 2024-09-04 | Dowden Nathan J President & COO | Shares withheld for taxes | −983 | $15.42 | $15K | 128,470 |
| 2024-09-04 | Sethuraman Natarajan Chief Scientific Officer | Shares withheld for taxes | −955 | $15.42 | $15K | 187,225 |
| 2024-09-04 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −941 | $15.42 | $15K | 79,846 |
| 2024-09-03 | Doshi Dipal CEO | Shares withheld for taxes | −2,328 | $15.76 | $37K | 332,147 |
| 2024-09-03 | Doshi Dipal CEO | Shares withheld for taxes | −752 | $16.93 | $13K | 331,395 |
| 2024-09-03 | Doshi Dipal CEO | Shares withheld for taxes | −72 | $17.70 | $1K | 331,323 |
| 2024-09-03 | Dowden Nathan J President & COO | Shares withheld for taxes | −483 | $15.76 | $8K | 129,624 |
| 2024-09-03 | Dowden Nathan J President & COO | Shares withheld for taxes | −156 | $16.93 | $3K | 129,468 |
| 2024-09-03 | Dowden Nathan J President & COO | Shares withheld for taxes | −15 | $17.70 | $266 | 129,453 |
| 2024-09-03 | Sethuraman Natarajan Chief Scientific Officer | Shares withheld for taxes | −469 | $15.76 | $7K | 188,345 |
| 2024-09-03 | Sethuraman Natarajan Chief Scientific Officer | Shares withheld for taxes | −151 | $16.93 | $3K | 188,194 |
| 2024-09-03 | Sethuraman Natarajan Chief Scientific Officer | Shares withheld for taxes | −14 | $17.70 | $248 | 188,180 |
| 2024-09-03 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −462 | $15.76 | $7K | 80,950 |
| 2024-09-03 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −149 | $16.93 | $3K | 80,801 |
| 2024-09-03 | WENTWORTH KORY JAMES Chief Financial Officer | Shares withheld for taxes | −14 | $17.70 | $248 | 80,787 |
| 2024-08-16 | Dowden Nathan J President & COO | Option exercise 10b5-1 | +20,000 | $1.74 | $35K | 157,204 |
Page 9 of 12 · 230 trades